2023
DOI: 10.1172/jci170027
|View full text |Cite
|
Sign up to set email alerts
|

Ferroptosis: the vulnerability within a cancer monster

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 28 publications
0
3
0
Order By: Relevance
“…The upstream molecular of ACSL4, cyclin-dependent kinase 1 (CDK1) can mediate ubiquitin-mediated degradation of ACSL4 via phosphorylating ACSL4 and recruiting ubiquitin ligase E3 component N-recognition protein 5 (UBR5), ultimately causing ferroptosis and chemotherapy resistance in CRC [138]. RB1 is another upstream suppressor of ACSL4, whose loss can activate transcription factor E2F1 binding to the promoter of ACSL4 by increasing the transcriptional levels of E2F1, thus promoting the occurrence of ferroptosis [139]. These findings provide a novel therapeutic target for RB1-deficient cancers.…”
Section: Fatty Acidsmentioning
confidence: 99%
“…The upstream molecular of ACSL4, cyclin-dependent kinase 1 (CDK1) can mediate ubiquitin-mediated degradation of ACSL4 via phosphorylating ACSL4 and recruiting ubiquitin ligase E3 component N-recognition protein 5 (UBR5), ultimately causing ferroptosis and chemotherapy resistance in CRC [138]. RB1 is another upstream suppressor of ACSL4, whose loss can activate transcription factor E2F1 binding to the promoter of ACSL4 by increasing the transcriptional levels of E2F1, thus promoting the occurrence of ferroptosis [139]. These findings provide a novel therapeutic target for RB1-deficient cancers.…”
Section: Fatty Acidsmentioning
confidence: 99%
“…This is consistent with the fact that GPX4 is abundantly expressed in most cancer cells. However, this strong ferroptotic potential is unblocked when RB1-deficient cells are treated with GPX4 inhibitors, resulting in massive ferroptosis [98].…”
Section: Pathways Associated With Both Iron Death and Tumor Progressionmentioning
confidence: 99%
“…This is consistent with the fact that GPX4 is abundantly expressed in most cancer cells. However, this strong ferroptotic potential is unblocked when RB1-deficient cells are treated with GPX4 inhibitors, resulting in massive ferroptosis [97].…”
Section: Relationship Between Ferroptosis and Cancer Angiogenesis Inv...mentioning
confidence: 99%